Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use COARTEM Tablets safely and effectively. See full prescribing information for COARTEM Tablets. COARTEM® (artemether/lumefantrine) Tablets Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
Coartem (artemether/lumefantrine) Tablets are indicated for treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients of 5 kg bodyweight and above. Coartem Tablets have been shown to be effective in geographical regions where resistance to chloroquine has been reported [see Clinical Studies (14.1)]. Limitations of Use : Coartem Tablets are not approved for patients with severe or complicated P. falciparum malaria. Coartem Tablets are not approved for the prevention of malaria.
- generic_name
- artemether and lumefantrine
- product_names
- artemether and lumefantrine
- ndc
- 76413-154, 0078-0568, 76413-154-24, 76413-154-18, 76413-154-12, 76413-154-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en